コンテンツへスキップ
Merck

1.20091

Silica

EMPROVE® ESSENTIAL, Ph. Eur., NF

別名:

Silicon dioxide, 二酸化ケイ素

ログインで組織・契約価格をご覧ください。

サイズを選択してください

この商品について

化学式:
SiO2
CAS番号:
7631-86-9
分子量:
60.08
UNSPSC Code:
12352201
MDL number:
MFCD00011232

主要文書

すべての文書を表示
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします

製品名

Silica, EMPROVE® ESSENTIAL, Ph. Eur., NF

InChI key

VYPSYNLAJGMNEJ-UHFFFAOYSA-N

InChI

1S/O2Si/c1-3-2

SMILES string

O=[Si]=O

agency

NF
Ph. Eur.

product line

EMPROVE® ESSENTIAL

form

fine powder

particle size

17-25 μm (d50)

bp

2230 °C (lit.)

mp

>1600 °C (lit.)
1710 °C

application(s)

pharmaceutical
pharmaceutical
solid formulation
solubility enhancement

storage temp.

2-30°C

Quality Level

500

類似した製品をお探しですか？ 訪問 製品比較ガイド

関連するカテゴリー

Application

Parteck® SLC excipient is an innovative silica drug carrier that enhances drug solubility thanks to its unique surface structure, which can stabilize the amorphous state. This is especially relevant for poor glass forming APIs, which can be difficult to stabilize with other formulation technologies. Parteck® SLC is also emerging as a first-in-class excipient to reduce the risk of unstable polymorphism and particle properties in drug development. In this application, Parteck® SLC can homogenize both properties in a template-based formulation approach, with robust and reliable results.

Features and Benefits

  • Solubility enhancement of APIs
  • Unparalleled stabilization of the amorphous solid state
  • Unique pore structure (6 nm diameter) and a very high surface area (500 m²/g)
  • Perfect fit to stabilize poor glass former molecules
  • Platform approach to manage API particle and polymorph variation
  • No specific equipment/extra capital invest needed to stabilize the amorphous form of APIs
  • High-end application support

General description

With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Packaging

1200910300 // Wide necked plastic bottle in corrugated box
1200911000 // Wide necked plastic bottle in corrugated box
1200919025 // Standard PE bag in PE square drum

Legal Information

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

保管分類

13 - Non Combustible Solids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

試験成績書（COA）

製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

資料

Enhance Solubility With 3D Printing and Mesoporous Silica

Accelerate formulation of APIs with solubility challenges using additive manufacturing (3D printing) with mesoporous silica. Explore this case study!

API Solubility and Dissolution Enhancement Via Formulation

Our overview of API solubility and dissolution enhancement methods can help you decide between the many options to take during formulation.

Improving API Solubility with Mesoporous Silica

Discover how mesoporous silica enhances API solubility, unlocking the full potential of promising drugs with improved bioavailability.

グローバルトレードアイテム番号

カタログ番号GTIN
1.20091.100004027269967574
1.20091.902504054839236228

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら（テクニカルサービス）